Veru Inc. (VERU) Financials
VERU Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 37.0 million | 8.7 million |
| March 31, 2026 | 43.1 million | 8.3 million |
| Dec. 31, 2025 | 47.6 million | 10.4 million |
| Sept. 30, 2025 | 29.8 million | 11.5 million |
VERU Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -5.5 million | -1.2 million |
| March 31, 2026 | -8.9 million | 402712 |
| Dec. 31, 2025 | -6.2 million | 757605 |
| Sept. 30, 2025 | -5.5 million | 1.5 million |
VERU Net Income
No data available :(
VERU Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 23.9 million | 1.9 million | - |
| March 31, 2026 | 30.8 million | - | 2.8 million |
| Dec. 31, 2025 | 35.4 million | - | 3.0 million |
| Sept. 30, 2025 | 18.3 million | - | 3.1 million |
VERU Shares Outstanding
VERU Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 5 | 4.4 million | 3.4 million | - |
| March 31, 2026 | 5 | 3.1 million | 4.1 million | - |
| Dec. 31, 2025 | - | 1.3 million | 4.1 million | - |
| Sept. 30, 2025 | 4 | 2.9 million | 4.5 million | -9.3 million |
VERU Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | 56386 | 28194 |
| Dec. 31, 2025 | - | 28193 |
| Sept. 30, 2025 | 247064 | 28573 |
VERU Revenue by Segment
Graph available only for paid members. Upgrade to see it.
VERU
Price: $2.59
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.61 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.1 million
Ebitda: -7.3 millionMarket Capitalization: 46.5 million